We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$1.3B
AUM Growth
+$198M
Cap. Flow
+$75.1M
Cap. Flow %
5.78%
Top 10 Hldgs %
26.62%
Holding
265
New
28
Increased
44
Reduced
124
Closed
7

Top Sells

Rank Stock Value
1
MRSH
Marsh
MRSH
+$2.74M
2
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$1.4M
3
AAPL icon
Apple
AAPL
+$1.21M
4
JNJ icon
Johnson & Johnson
JNJ
+$1.16M
5
AFL icon
Aflac
AFL
+$1.09M

Sector Composition

Rank Sector Weight
1 Technology 21.95%
2 Healthcare 14.97%
3 Financials 8.17%
4 Industrials 8.04%
5 Consumer Discretionary 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
151
Accenture
ACN
$108B
$1.13M 0.09%
4,317
-75
-2% -$18K
FIS icon
152
Fidelity National Information Services
FIS
$22.1B
$1.1M 0.08%
7,754
-431
-5% -$61.5K
VO icon
153
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$1.1M 0.08%
21,200
MDT icon
154
Medtronic
MDT
$112B
$1.08M 0.08%
9,236
+865
+10% +$95.2K
VOO icon
155
Vanguard S&P 500 ETF
VOO
$1.03T
$1.08M 0.08%
3,135
+559
+22% +$182K
BRK.A icon
156
Berkshire Hathaway Class A
BRK.A
$1.12T
$1.04M 0.08%
3
IAU icon
157
iShares Gold Trust
IAU
$64.4B
$1.02M 0.08%
+28,275
New +$1.01M
NTRS icon
158
Northern Trust
NTRS
$33.9B
$1.01M 0.08%
10,845
-1,550
-13% -$137K
UNH icon
159
UnitedHealth
UNH
$370B
$994K 0.08%
2,833
+145
+5% +$48.6K
SWK icon
160
Stanley Black & Decker
SWK
$15.7B
$971K 0.07%
5,436
-282
-5% -$50K
IYW icon
161
iShares US Technology ETF
IYW
$25.5B
$953K 0.07%
11,200
WMT icon
162
Walmart Inc
WMT
$890B
$943K 0.07%
19,632
+255
+1% +$12.4K
FCX icon
163
Freeport-McMoran
FCX
$97.5B
$923K 0.07%
35,482
-7,500
-17% -$156K
KMI icon
164
Kinder Morgan
KMI
$68.7B
$913K 0.07%
66,783
-9,748
-13% -$130K
BSX icon
165
Boston Scientific
BSX
$71.5B
$901K 0.07%
25,055
-5,225
-17% -$188K
STE icon
166
Steris
STE
$23.1B
$896K 0.07%
4,725
-600
-11% -$112K
RLAY icon
167
Relay Therapeutics
RLAY
$4.33B
$878K 0.07%
21,121
T icon
168
AT&T
T
$163B
$838K 0.06%
38,599
-38,066
-50% -$821K
MOTI icon
169
VanEck Morningstar International Moat ETF
MOTI
$76.9M
$826K 0.06%
24,557
-1,120
-4% -$35.6K
INTU icon
170
Intuit
INTU
$89B
$761K 0.06%
2,004
STWD icon
171
Starwood Property Trust
STWD
$6.09B
$760K 0.06%
39,376
-3,109
-7% -$52.9K
SWKS icon
172
Skyworks Solutions
SWKS
$10.6B
$754K 0.06%
4,930
EMR icon
173
Emerson Electric
EMR
$88.3B
$750K 0.06%
9,338
-125
-1% -$9.29K
IGM icon
174
iShares Expanded Tech Sector ETF
IGM
$10.8B
$700K 0.05%
12,000
IVE icon
175
iShares S&P 500 Value ETF
IVE
$49.8B
$696K 0.05%
5,435

Similar funds

Boston Family Office's Q4 2020 Portfolio in Review

As of Q4 2020, Boston Family Office held 265 positions worth $1.3B, up 18% from $1.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Boston Family Office deployed $75.1M of net new capital in Q4 2020, opening 28 new positions and adding to 44 existing holdings. Its largest new stake was Vanguard Short-Term Bond ETF: 253,733 shares worth $21M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Marsh, an estimated $2.74M trimmed.

  • Boston Family Office's largest Q4 2020 buy was Vanguard Short-Term Bond ETF: 253,733 shares worth $21M.
  • Boston Family Office added most to SolarEdge in Q4 2020, an estimated $2.89M increase.
  • Boston Family Office's biggest Q4 2020 reduction was Marsh, cutting an estimated $2.74M.
  • Boston Family Office fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $1.4M.
  • Boston Family Office's ten largest holdings make up 27% of its $1.3B portfolio in Q4 2020.
  • Boston Family Office opened 28 new positions and closed 7 in Q4 2020.
  • Boston Family Office's portfolio value rose 18% quarter-over-quarter to $1.3B.

Based on Boston Family Office's 13F filing for Q4 2020, filed 16 Feb 2021.